(BHM) Bluerock Homes Trust - Ratings and Ratios
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock •
BHM: Single-Family, Residential, Units, Homes, Properties, Rentals
Bluerock Homes Trust, Inc. (NYSE MKT:BHM) is a real estate investment trust (REIT) specializing in the ownership and operation of single-family properties. Its strategic focus is on high-growth regions, particularly the Sunbelt and Western United States, where demographic trends and migration patterns drive demand for housing. As of December 31, 2023, the companys portfolio comprised 18 real estate investments, including 11 consolidated properties and 7 preferred equity and loan investments. This structure allows the company to diversify its exposure across different asset classes and risk profiles within the residential real estate sector.
As a REIT, Bluerock Homes Trust is required to distribute at least 90% of its taxable income to shareholders annually, enabling tax-efficient returns for investors. The companys incorporation in 2021 and headquarters in New York, New York, position it as a relatively new player in the REIT space, with a focus on scaling its portfolio in targeted markets. Its operational strategy emphasizes acquiring properties in regions with strong economic fundamentals, such as population growth, job market expansion, and limited housing supply.
From a technical perspective, BHMs stock has shown recent price action near $11.90, with short-term moving averages indicating potential support at $11.52 (SMA 20) and resistance at $12.16 (SMA 50). The SMA 200 at $15.09 suggests longer-term downward momentum. Average trading volume over the past 20 days is 2,937 shares, reflecting relatively low liquidity. The ATR of 0.34 indicates modest price volatility.
On the fundamental side, BHM has a market capitalization of $45.69 million, with a price-to-book ratio of 0.32, signaling that shares are trading below book value. The P/S ratio of 0.79 reflects a discount relative to sales, while the negative return on equity (-0.54) highlights current profitability challenges. The lack of forward P/E suggests limited visibility into future earnings.
Additional Sources for BHM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BHM Stock Overview
Market Cap in USD | 47m |
Sector | Real Estate |
Industry | REIT - Residential |
GiC Sub-Industry | Real Estate Development |
IPO / Inception | 2022-10-06 |
BHM Stock Ratings
Growth 5y | -55.3% |
Fundamental | 30.3% |
Dividend | 1.0% |
Rel. Strength Industry | -29.1 |
Analysts | - |
Fair Price Momentum | 10.88 USD |
Fair Price DCF | 67.65 USD |
BHM Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 1.0% |
BHM Growth Ratios
Growth Correlation 3m | -71.7% |
Growth Correlation 12m | -82% |
Growth Correlation 5y | -55.3% |
CAGR 5y | -18.15% |
CAGR/Max DD 5y | -0.33 |
Sharpe Ratio 12m | -0.40 |
Alpha | -25.22 |
Beta | -0.17 |
Volatility | 26.70% |
Current Volume | 3.1k |
Average Volume 20d | 3.2k |
As of March 17, 2025, the stock is trading at USD 12.38 with a total of 3,138 shares traded.
Over the past week, the price has changed by +4.03%, over one month by +7.00%, over three months by -12.07% and over the past year by -22.14%.
Neither. Based on ValueRay Fundamental Analyses, Bluerock Homes Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHM as of March 2025 is 10.88. This means that BHM is currently overvalued and has a potential downside of -12.12%.
Bluerock Homes Trust has no consensus analysts rating.
According to ValueRays Forecast Model, BHM Bluerock Homes Trust will be worth about 11.8 in March 2026. The stock is currently trading at 12.38. This means that the stock has a potential downside of -5.09%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.8 | -5.1% |